Balancing Big Pharma's books
- PMID: 18292166
- PMCID: PMC2249705
- DOI: 10.1136/bmj.39491.469005.94
Balancing Big Pharma's books
Abstract
With patents running out on their big earning products and recent scandals undermining their image, drug companies are under pressure. Andrew Jack reports on their problems
Conflict of interest statement
Competing interests: None declared.
References
-
- Institute for the Quality and Efficiency in Healthcare. Evaluation of the effects of statins (with particular consideration of atorvastatin) Cologne, 2006. www.iqwig.de/download/06-01-30_Finaler__Evaluation_of_the_effects_of_sta...
-
- Food and Drug Administration. Pfizer stops all torcetrapib clinical trials in interest of patient safety. 2006. www.fda.gov/bbs/topics/NEWS/2006/NEW01514.html
-
- Pfizer. Third quarter earnings teleconference, 18 October 2007 www.pfizer.com/files/investors/q3earnings_october182007.pdf .
-
- Kroes N. European Commissioner for competition policy commission launches sector inquiry into pharmaceuticals Press release , 16 Jan 2008. http://europa.eu/rapid/pressReleasesAction.do?reference=SPEECH/08/18&for...
MeSH terms
LinkOut - more resources
Full Text Sources